insights_auto
Why is DBVT down 4.41%?
Dive Deeperchevron_right
DBVT:NASDAQ
DBV Technologies SA - ADR
$9.98
arrow_downward
-4.41%(-0.46) 1D
$9.98
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBVT...
Open
$10.64
High
$10.66
Low
$9.82
Mkt. cap
643.23M
Avg. vol.
326.23K
Volume
558.01K
52-wk high
$26.18
52-wk low
$9.82
EPS
-$3.57
Beta
-1.04
Shares outstanding
62.88M
No. of employees
170
Open
$10.64
High
$10.66
Low
$9.82
Mkt. cap
643.23M
Avg. vol.
326.23K
Volume
558.01K
52-wk high
$26.18
52-wk low
$9.82
EPS
-$3.57
Beta
-1.04
Shares outstanding
62.88M
No. of employees
170
News stories
From web sources and news partners
Ideal Investisseur
·
1 day ago
DBV Technologies shares decline nearly 3%, among the largest drops in the SBF 120
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA - ADR